Business Description
Botanix Pharmaceuticals Ltd
NAICS : 325414
SIC : 2836
ISIN : AU000000BOT2
Description
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 137.54 | |||||
| Beneish M-Score | 1.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -44.2 | |||||
| 3-Year EPS without NRI Growth Rate | -44.2 | |||||
| 3-Year FCF Growth Rate | -78.3 | |||||
| 3-Year Book Growth Rate | 41.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 606.44 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 86.18 | |||||
| 9-Day RSI | 81.62 | |||||
| 14-Day RSI | 76.75 | |||||
| 6-1 Month Momentum % | 15.38 | |||||
| 12-1 Month Momentum % | 108.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.21 | |||||
| Quick Ratio | 21.89 | |||||
| Cash Ratio | 21.25 | |||||
| Days Sales Outstanding | 204.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23 | |||||
| Shareholder Yield % | -11.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -2567.94 | |||||
| Net Margin % | -2303.99 | |||||
| FCF Margin % | -4340.03 | |||||
| ROE % | -23.5 | |||||
| ROA % | -22.49 | |||||
| ROIC % | -66.54 | |||||
| 3-Year ROIIC % | -17.85 | |||||
| ROC (Joel Greenblatt) % | -1525.87 | |||||
| ROCE % | -23.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 23.75 | |||||
| PB Ratio | 7.92 | |||||
| Price-to-Tangible-Book | 10.8 | |||||
| EV-to-EBIT | -61.41 | |||||
| EV-to-EBITDA | -61.74 | |||||
| EV-to-Revenue | 1413.76 | |||||
| EV-to-FCF | -32.57 | |||||
| Price-to-Net-Current-Asset-Value | 11.88 | |||||
| Price-to-Net-Cash | 11.88 | |||||
| Earnings Yield (Greenblatt) % | -1.63 | |||||
| FCF Yield % | -3.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Botanix Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.602 | ||
| EPS (TTM) (A$) | -0.009 | ||
| Beta | 2.09 | ||
| Volatility % | 51.93 | ||
| 14-Day RSI | 76.75 | ||
| 14-Day ATR (A$) | 0.023685 | ||
| 20-Day SMA (A$) | 0.41525 | ||
| 12-1 Month Momentum % | 108.33 | ||
| 52-Week Range (A$) | 0.1625 - 0.485 | ||
| Shares Outstanding (Mil) | 1,825.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Botanix Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Botanix Pharmaceuticals Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Botanix Pharmaceuticals Ltd Frequently Asked Questions
What is Botanix Pharmaceuticals Ltd(ASX:BOT)'s stock price today?
The current price of ASX:BOT is A$0.48. The 52 week high of ASX:BOT is A$0.49 and 52 week low is A$0.16.
When is next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT)?
The next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT) is .
Does Botanix Pharmaceuticals Ltd(ASX:BOT) pay dividends? If so, how much?
Botanix Pharmaceuticals Ltd(ASX:BOT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers